查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1867553

醫療第二意見：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Medical Second Opinion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 124 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球醫療第二意見市場預計在 2024 年達到 69.73 億美元，預計到 2031 年將達到 179.48 億美元，在預測期（2025-2031 年）內以 14.8% 的複合年成長率成長。

醫療第二意見是一種專門的醫療服務，患者在獲得初步診斷或治療提案後，可向獨立的、合格的醫療專業人員請求重新評估。這可能包括對診斷、治療方案以及是否需要手術的審查。這項服務通常透過遠距醫療、線上平台和國際合作提供，尤其適用於嚴重或罕見疾病以及涉及複雜治療性介入的病例。其目標是減少誤診、提高治療準確性並建立患者信任。隨著遠距遠端醫療、全球醫療合作以及人工智慧驅動的診斷技術的進步，醫療第二意見正逐漸成為高階醫療服務、保險服務和跨境轉診生態系統的重要組成部分。

隨著醫療決策日益複雜，醫療第二意見服務市場正經歷快速成長。年度報告顯示，全球高所得階層越來越重視取得優質醫療資源，越來越多的患者尋求確認和最佳化治療方案，尤其是在腫瘤、心血管疾病和罕見疾病領域。保險公司正將第二意見服務納入重大疾病和健康保險產品，以提升客戶參與和忠誠度。美國、德國和新加坡等國政府也已將第二意見納入其報銷體系和法律體制，以增強其公信力。同時，人工智慧輔助診斷、國際遠端醫療平台和全球醫療專家網路的整合顯著提高了這些服務的可近性和準確性。

儘管人們對醫療第二意見服務的興趣日益濃厚，但該服務仍面臨制度和運作方面的許多障礙。跨境服務因醫療體系的多樣性、醫療記錄的不標準化以及資料互通性問題而變得複雜。先進的醫療技術仍集中在少數頂尖機構，限制了服務供給面的擴充性。許多地區的支付機制尚不明確，保險覆蓋範圍也不足以支持服務的廣泛普及。此外，跨境資料共用中存在的資料隱私和監管合規問題也構成法律風險。對於新興的醫療服務提供者而言，建立值得信賴的合格醫生網路、確保服務品質的一致性以及與醫院建立合作關係都是至關重要但又極具挑戰性的難題。

在個人化醫療和病患賦權的推動下，第二意見服務正從小眾的高階附加服務發展成為臨床診療的標配。 「診斷+專家複核」的整合式服務包日益普及，尤其是在癌症、心血管疾病和神經系統疾病領域。數位健康平台和遠端醫療提供者正將第二意見功能融入更廣泛的生態系統，其中包括人工智慧影像分析、自動化結構化醫療記錄以及國際專家資源。在亞洲和中東等快速成長的地區，高淨值人士和重大疾病保險投保人正在推動第二診療意見服務的普及，引領業界朝向更個人化、全球化和平台化的模式發展。

本報告旨在對全球醫療第二意見市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名，以及按地區/國家、類型和應用對醫療第二意見進行分析。

醫療第二意見市場規模、估算和預測均以銷售收入為指標，以 2024 年為基準年，並包含 2020 年至 2031 年的歷史數據和預測數據。我們運用定量和定性分析，幫助讀者制定業務/成長策略，評估市場競爭格局，分析公司在當前市場中的地位，並就醫療第二意見做出明智的商業決策。

市場區隔

公司

  • HCA Hospitals
  • AXA PPP Healthcare
  • Royal London Group
  • Helsana Group
  • Cleveland Clinic
  • Amradnet
  • Best Doctors
  • Inova Care
  • Toranomon Hospital
  • Keio University Hospital
  • Johns Hopkins Medicine
  • Penn Medicine
  • Oncology International Pvt. Ltd.
  • GrandOpinion
  • London Pain Clinic
  • Mondial Assistance
  • Medisense
  • Medo Asia Sdn. Bhd.

按類型分類的細分市場

  • 醫院
  • 醫療第二意見提供者
  • 健康保險公司

應用領域

  • 癌症
  • 糖尿病
  • 心臟病
  • 神經系統疾病
  • 眼部疾病
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Medical Second Opinion was estimated to be worth US$ 6973 million in 2024 and is forecast to a readjusted size of US$ 17948 million by 2031 with a CAGR of 14.8% during the forecast period 2025-2031.

Medical Second Opinion refers to a professional healthcare service where a patient, after receiving an initial diagnosis or treatment recommendation, consults an independent, qualified medical expert for a reevaluation. This may include a review of diagnosis, therapeutic plan, or surgical necessity. The service is typically delivered through remote consultations, online platforms, or international collaborations, especially in cases involving critical illness, rare diseases, or complex interventions. It aims to reduce misdiagnosis, enhance treatment accuracy, and build patient confidence. With the advancement of telemedicine, global healthcare connectivity, and AI-driven diagnostics, Medical Second Opinion is emerging as a critical component in premium healthcare offerings, insurance services, and cross-border referral ecosystems.

As medical decisions become more complex, the market for Medical Second Opinion services is experiencing rapid growth. According to annual reports, global high-net-worth and middle-class populations are increasingly seeking access to premium healthcare resources, especially in oncology, cardiovascular diseases, and rare conditions where patients demand confirmation and optimized treatment plans. Insurance providers are embedding second opinion services into critical illness and health insurance products, improving customer engagement and loyalty. Governments in countries like the U.S., Germany, and Singapore have incorporated second opinions into reimbursement or legal frameworks, enhancing credibility. Meanwhile, the integration of AI-assisted diagnostics, international telemedicine platforms, and global medical expert networks has significantly improved the accessibility and accuracy of these services.

Despite growing interest, Medical Second Opinion services face systemic and operational barriers. Cross-border service delivery is complicated by diverse healthcare systems, lack of standardized medical records, and data interoperability issues. High-level medical expertise remains concentrated in a few top institutions, limiting supply-side scalability. In many regions, payment mechanisms are unclear, and insurance coverage is insufficient to support widespread adoption. Additionally, concerns about data privacy and regulatory compliance for cross-border data sharing pose legal risks. For emerging providers, building trust networks of qualified physicians, ensuring consistent service quality, and forming hospital partnerships are critical but challenging.

Driven by the rise of personalized medicine and patient empowerment, Medical Second Opinion services are evolving from a niche premium add-on to a standard component of clinical care. Integrated packages offering "diagnosis + expert review" are gaining popularity, particularly for cancers, cardiovascular, and neurological diseases. Digital health platforms and telemedicine providers are embedding second opinion modules into broader ecosystems that include AI imaging analysis, auto-structured medical records, and access to international experts. In fast-growing regions such as Asia and the Middle East, high-net-worth individuals and critical illness policyholders are fueling adoption, pushing the industry toward greater personalization, globalization, and platform-based models.

This report aims to provide a comprehensive presentation of the global market for Medical Second Opinion, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical Second Opinion by region & country, by Type, and by Application.

The Medical Second Opinion market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Second Opinion.

Market Segmentation

By Company

  • HCA Hospitals
  • AXA PPP Healthcare
  • Royal London Group
  • Helsana Group
  • Cleveland Clinic
  • Amradnet
  • Best Doctors
  • Inova Care
  • Toranomon Hospital
  • Keio University Hospital
  • Johns Hopkins Medicine
  • Penn Medicine
  • Oncology International Pvt. Ltd.
  • GrandOpinion
  • London Pain Clinic
  • Mondial Assistance
  • Medisense
  • Medo Asia Sdn. Bhd.

Segment by Type

  • Hospitals
  • Medical Second Opinion Providing Companies
  • Health Insurance Companies

Segment by Application

  • Cancer
  • Diabetes
  • Cardiac Disorders
  • Neurological Disorders
  • Ocular Disorders
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Medical Second Opinion company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Medical Second Opinion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Medical Second Opinion in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Medical Second Opinion Product Introduction
  • 1.2 Global Medical Second Opinion Market Size Forecast (2020-2031)
  • 1.3 Medical Second Opinion Market Trends & Drivers
    • 1.3.1 Medical Second Opinion Industry Trends
    • 1.3.2 Medical Second Opinion Market Drivers & Opportunity
    • 1.3.3 Medical Second Opinion Market Challenges
    • 1.3.4 Medical Second Opinion Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Medical Second Opinion Players Revenue Ranking (2024)
  • 2.2 Global Medical Second Opinion Revenue by Company (2020-2025)
  • 2.3 Key Companies Medical Second Opinion Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Medical Second Opinion Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Medical Second Opinion
  • 2.6 Medical Second Opinion Market Competitive Analysis
    • 2.6.1 Medical Second Opinion Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Medical Second Opinion Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Second Opinion as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Hospitals
    • 3.1.2 Medical Second Opinion Providing Companies
    • 3.1.3 Health Insurance Companies
  • 3.2 Global Medical Second Opinion Sales Value by Type
    • 3.2.1 Global Medical Second Opinion Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Medical Second Opinion Sales Value, by Type (2020-2031)
    • 3.2.3 Global Medical Second Opinion Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Cancer
    • 4.1.2 Diabetes
    • 4.1.3 Cardiac Disorders
    • 4.1.4 Neurological Disorders
    • 4.1.5 Ocular Disorders
    • 4.1.6 Others
  • 4.2 Global Medical Second Opinion Sales Value by Application
    • 4.2.1 Global Medical Second Opinion Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Medical Second Opinion Sales Value, by Application (2020-2031)
    • 4.2.3 Global Medical Second Opinion Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Medical Second Opinion Sales Value by Region
    • 5.1.1 Global Medical Second Opinion Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Medical Second Opinion Sales Value by Region (2020-2025)
    • 5.1.3 Global Medical Second Opinion Sales Value by Region (2026-2031)
    • 5.1.4 Global Medical Second Opinion Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Medical Second Opinion Sales Value, 2020-2031
    • 5.2.2 North America Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Medical Second Opinion Sales Value, 2020-2031
    • 5.3.2 Europe Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Medical Second Opinion Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Medical Second Opinion Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Medical Second Opinion Sales Value, 2020-2031
    • 5.5.2 South America Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Medical Second Opinion Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Medical Second Opinion Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Medical Second Opinion Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Medical Second Opinion Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Medical Second Opinion Sales Value, 2020-2031
    • 6.3.2 United States Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Medical Second Opinion Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Medical Second Opinion Sales Value, 2020-2031
    • 6.4.2 Europe Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Medical Second Opinion Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Medical Second Opinion Sales Value, 2020-2031
    • 6.5.2 China Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Medical Second Opinion Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Medical Second Opinion Sales Value, 2020-2031
    • 6.6.2 Japan Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Medical Second Opinion Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Medical Second Opinion Sales Value, 2020-2031
    • 6.7.2 South Korea Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Medical Second Opinion Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Medical Second Opinion Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Medical Second Opinion Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Medical Second Opinion Sales Value, 2020-2031
    • 6.9.2 India Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Medical Second Opinion Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 HCA Hospitals
    • 7.1.1 HCA Hospitals Profile
    • 7.1.2 HCA Hospitals Main Business
    • 7.1.3 HCA Hospitals Medical Second Opinion Products, Services and Solutions
    • 7.1.4 HCA Hospitals Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.1.5 HCA Hospitals Recent Developments
  • 7.2 AXA PPP Healthcare
    • 7.2.1 AXA PPP Healthcare Profile
    • 7.2.2 AXA PPP Healthcare Main Business
    • 7.2.3 AXA PPP Healthcare Medical Second Opinion Products, Services and Solutions
    • 7.2.4 AXA PPP Healthcare Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.2.5 AXA PPP Healthcare Recent Developments
  • 7.3 Royal London Group
    • 7.3.1 Royal London Group Profile
    • 7.3.2 Royal London Group Main Business
    • 7.3.3 Royal London Group Medical Second Opinion Products, Services and Solutions
    • 7.3.4 Royal London Group Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Royal London Group Recent Developments
  • 7.4 Helsana Group
    • 7.4.1 Helsana Group Profile
    • 7.4.2 Helsana Group Main Business
    • 7.4.3 Helsana Group Medical Second Opinion Products, Services and Solutions
    • 7.4.4 Helsana Group Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Helsana Group Recent Developments
  • 7.5 Cleveland Clinic
    • 7.5.1 Cleveland Clinic Profile
    • 7.5.2 Cleveland Clinic Main Business
    • 7.5.3 Cleveland Clinic Medical Second Opinion Products, Services and Solutions
    • 7.5.4 Cleveland Clinic Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Cleveland Clinic Recent Developments
  • 7.6 Amradnet
    • 7.6.1 Amradnet Profile
    • 7.6.2 Amradnet Main Business
    • 7.6.3 Amradnet Medical Second Opinion Products, Services and Solutions
    • 7.6.4 Amradnet Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Amradnet Recent Developments
  • 7.7 Best Doctors
    • 7.7.1 Best Doctors Profile
    • 7.7.2 Best Doctors Main Business
    • 7.7.3 Best Doctors Medical Second Opinion Products, Services and Solutions
    • 7.7.4 Best Doctors Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Best Doctors Recent Developments
  • 7.8 Inova Care
    • 7.8.1 Inova Care Profile
    • 7.8.2 Inova Care Main Business
    • 7.8.3 Inova Care Medical Second Opinion Products, Services and Solutions
    • 7.8.4 Inova Care Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Inova Care Recent Developments
  • 7.9 Toranomon Hospital
    • 7.9.1 Toranomon Hospital Profile
    • 7.9.2 Toranomon Hospital Main Business
    • 7.9.3 Toranomon Hospital Medical Second Opinion Products, Services and Solutions
    • 7.9.4 Toranomon Hospital Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Toranomon Hospital Recent Developments
  • 7.10 Keio University Hospital
    • 7.10.1 Keio University Hospital Profile
    • 7.10.2 Keio University Hospital Main Business
    • 7.10.3 Keio University Hospital Medical Second Opinion Products, Services and Solutions
    • 7.10.4 Keio University Hospital Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Keio University Hospital Recent Developments
  • 7.11 Johns Hopkins Medicine
    • 7.11.1 Johns Hopkins Medicine Profile
    • 7.11.2 Johns Hopkins Medicine Main Business
    • 7.11.3 Johns Hopkins Medicine Medical Second Opinion Products, Services and Solutions
    • 7.11.4 Johns Hopkins Medicine Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Johns Hopkins Medicine Recent Developments
  • 7.12 Penn Medicine
    • 7.12.1 Penn Medicine Profile
    • 7.12.2 Penn Medicine Main Business
    • 7.12.3 Penn Medicine Medical Second Opinion Products, Services and Solutions
    • 7.12.4 Penn Medicine Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Penn Medicine Recent Developments
  • 7.13 Oncology International Pvt. Ltd.
    • 7.13.1 Oncology International Pvt. Ltd. Profile
    • 7.13.2 Oncology International Pvt. Ltd. Main Business
    • 7.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Products, Services and Solutions
    • 7.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Oncology International Pvt. Ltd. Recent Developments
  • 7.14 GrandOpinion
    • 7.14.1 GrandOpinion Profile
    • 7.14.2 GrandOpinion Main Business
    • 7.14.3 GrandOpinion Medical Second Opinion Products, Services and Solutions
    • 7.14.4 GrandOpinion Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.14.5 GrandOpinion Recent Developments
  • 7.15 London Pain Clinic
    • 7.15.1 London Pain Clinic Profile
    • 7.15.2 London Pain Clinic Main Business
    • 7.15.3 London Pain Clinic Medical Second Opinion Products, Services and Solutions
    • 7.15.4 London Pain Clinic Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.15.5 London Pain Clinic Recent Developments
  • 7.16 Mondial Assistance
    • 7.16.1 Mondial Assistance Profile
    • 7.16.2 Mondial Assistance Main Business
    • 7.16.3 Mondial Assistance Medical Second Opinion Products, Services and Solutions
    • 7.16.4 Mondial Assistance Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Mondial Assistance Recent Developments
  • 7.17 Medisense
    • 7.17.1 Medisense Profile
    • 7.17.2 Medisense Main Business
    • 7.17.3 Medisense Medical Second Opinion Products, Services and Solutions
    • 7.17.4 Medisense Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.17.5 Medisense Recent Developments
  • 7.18 Medo Asia Sdn. Bhd.
    • 7.18.1 Medo Asia Sdn. Bhd. Profile
    • 7.18.2 Medo Asia Sdn. Bhd. Main Business
    • 7.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Products, Services and Solutions
    • 7.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue (US$ Million) & (2020-2025)
    • 7.18.5 Medo Asia Sdn. Bhd. Recent Developments

8 Industry Chain Analysis

  • 8.1 Medical Second Opinion Industrial Chain
  • 8.2 Medical Second Opinion Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Medical Second Opinion Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Medical Second Opinion Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Medical Second Opinion Market Trends
  • Table 2. Medical Second Opinion Market Drivers & Opportunity
  • Table 3. Medical Second Opinion Market Challenges
  • Table 4. Medical Second Opinion Market Restraints
  • Table 5. Global Medical Second Opinion Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Medical Second Opinion Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Medical Second Opinion Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Medical Second Opinion Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Medical Second Opinion
  • Table 10. Global Medical Second Opinion Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Second Opinion as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Medical Second Opinion Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Medical Second Opinion Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Medical Second Opinion Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Medical Second Opinion Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Medical Second Opinion Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Medical Second Opinion Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Medical Second Opinion Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Medical Second Opinion Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Medical Second Opinion Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Medical Second Opinion Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Medical Second Opinion Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Medical Second Opinion Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Medical Second Opinion Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Medical Second Opinion Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Medical Second Opinion Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Medical Second Opinion Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Medical Second Opinion Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Medical Second Opinion Sales Value, (2026-2031) & (US$ Million)
  • Table 31. HCA Hospitals Basic Information List
  • Table 32. HCA Hospitals Description and Business Overview
  • Table 33. HCA Hospitals Medical Second Opinion Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Medical Second Opinion Business of HCA Hospitals (2020-2025)
  • Table 35. HCA Hospitals Recent Developments
  • Table 36. AXA PPP Healthcare Basic Information List
  • Table 37. AXA PPP Healthcare Description and Business Overview
  • Table 38. AXA PPP Healthcare Medical Second Opinion Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Medical Second Opinion Business of AXA PPP Healthcare (2020-2025)
  • Table 40. AXA PPP Healthcare Recent Developments
  • Table 41. Royal London Group Basic Information List
  • Table 42. Royal London Group Description and Business Overview
  • Table 43. Royal London Group Medical Second Opinion Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Medical Second Opinion Business of Royal London Group (2020-2025)
  • Table 45. Royal London Group Recent Developments
  • Table 46. Helsana Group Basic Information List
  • Table 47. Helsana Group Description and Business Overview
  • Table 48. Helsana Group Medical Second Opinion Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Medical Second Opinion Business of Helsana Group (2020-2025)
  • Table 50. Helsana Group Recent Developments
  • Table 51. Cleveland Clinic Basic Information List
  • Table 52. Cleveland Clinic Description and Business Overview
  • Table 53. Cleveland Clinic Medical Second Opinion Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Medical Second Opinion Business of Cleveland Clinic (2020-2025)
  • Table 55. Cleveland Clinic Recent Developments
  • Table 56. Amradnet Basic Information List
  • Table 57. Amradnet Description and Business Overview
  • Table 58. Amradnet Medical Second Opinion Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Medical Second Opinion Business of Amradnet (2020-2025)
  • Table 60. Amradnet Recent Developments
  • Table 61. Best Doctors Basic Information List
  • Table 62. Best Doctors Description and Business Overview
  • Table 63. Best Doctors Medical Second Opinion Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Medical Second Opinion Business of Best Doctors (2020-2025)
  • Table 65. Best Doctors Recent Developments
  • Table 66. Inova Care Basic Information List
  • Table 67. Inova Care Description and Business Overview
  • Table 68. Inova Care Medical Second Opinion Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Medical Second Opinion Business of Inova Care (2020-2025)
  • Table 70. Inova Care Recent Developments
  • Table 71. Toranomon Hospital Basic Information List
  • Table 72. Toranomon Hospital Description and Business Overview
  • Table 73. Toranomon Hospital Medical Second Opinion Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Medical Second Opinion Business of Toranomon Hospital (2020-2025)
  • Table 75. Toranomon Hospital Recent Developments
  • Table 76. Keio University Hospital Basic Information List
  • Table 77. Keio University Hospital Description and Business Overview
  • Table 78. Keio University Hospital Medical Second Opinion Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Medical Second Opinion Business of Keio University Hospital (2020-2025)
  • Table 80. Keio University Hospital Recent Developments
  • Table 81. Johns Hopkins Medicine Basic Information List
  • Table 82. Johns Hopkins Medicine Description and Business Overview
  • Table 83. Johns Hopkins Medicine Medical Second Opinion Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Medical Second Opinion Business of Johns Hopkins Medicine (2020-2025)
  • Table 85. Johns Hopkins Medicine Recent Developments
  • Table 86. Penn Medicine Basic Information List
  • Table 87. Penn Medicine Description and Business Overview
  • Table 88. Penn Medicine Medical Second Opinion Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Medical Second Opinion Business of Penn Medicine (2020-2025)
  • Table 90. Penn Medicine Recent Developments
  • Table 91. Oncology International Pvt. Ltd. Basic Information List
  • Table 92. Oncology International Pvt. Ltd. Description and Business Overview
  • Table 93. Oncology International Pvt. Ltd. Medical Second Opinion Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Medical Second Opinion Business of Oncology International Pvt. Ltd. (2020-2025)
  • Table 95. Oncology International Pvt. Ltd. Recent Developments
  • Table 96. GrandOpinion Basic Information List
  • Table 97. GrandOpinion Description and Business Overview
  • Table 98. GrandOpinion Medical Second Opinion Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Medical Second Opinion Business of GrandOpinion (2020-2025)
  • Table 100. GrandOpinion Recent Developments
  • Table 101. London Pain Clinic Basic Information List
  • Table 102. London Pain Clinic Description and Business Overview
  • Table 103. London Pain Clinic Medical Second Opinion Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Medical Second Opinion Business of London Pain Clinic (2020-2025)
  • Table 105. London Pain Clinic Recent Developments
  • Table 106. Mondial Assistance Basic Information List
  • Table 107. Mondial Assistance Description and Business Overview
  • Table 108. Mondial Assistance Medical Second Opinion Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Medical Second Opinion Business of Mondial Assistance (2020-2025)
  • Table 110. Mondial Assistance Recent Developments
  • Table 111. Medisense Basic Information List
  • Table 112. Medisense Description and Business Overview
  • Table 113. Medisense Medical Second Opinion Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Medical Second Opinion Business of Medisense (2020-2025)
  • Table 115. Medisense Recent Developments
  • Table 116. Medo Asia Sdn. Bhd. Basic Information List
  • Table 117. Medo Asia Sdn. Bhd. Description and Business Overview
  • Table 118. Medo Asia Sdn. Bhd. Medical Second Opinion Products, Services and Solutions
  • Table 119. Revenue (US$ Million) in Medical Second Opinion Business of Medo Asia Sdn. Bhd. (2020-2025)
  • Table 120. Medo Asia Sdn. Bhd. Recent Developments
  • Table 121. Key Raw Materials Lists
  • Table 122. Raw Materials Key Suppliers Lists
  • Table 123. Medical Second Opinion Downstream Customers
  • Table 124. Medical Second Opinion Distributors List
  • Table 125. Research Programs/Design for This Report
  • Table 126. Key Data Information from Secondary Sources
  • Table 127. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Medical Second Opinion Product Picture
  • Figure 2. Global Medical Second Opinion Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Medical Second Opinion Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Medical Second Opinion Report Years Considered
  • Figure 5. Global Medical Second Opinion Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Medical Second Opinion Revenue in 2024
  • Figure 7. Medical Second Opinion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Hospitals Picture
  • Figure 9. Medical Second Opinion Providing Companies Picture
  • Figure 10. Health Insurance Companies Picture
  • Figure 11. Global Medical Second Opinion Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Medical Second Opinion Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Cancer
  • Figure 14. Product Picture of Diabetes
  • Figure 15. Product Picture of Cardiac Disorders
  • Figure 16. Product Picture of Neurological Disorders
  • Figure 17. Product Picture of Ocular Disorders
  • Figure 18. Product Picture of Others
  • Figure 19. Global Medical Second Opinion Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 20. Global Medical Second Opinion Sales Value Market Share by Application, 2024 & 2031
  • Figure 21. North America Medical Second Opinion Sales Value (2020-2031) & (US$ Million)
  • Figure 22. North America Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
  • Figure 23. Europe Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. Europe Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Asia Pacific Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Asia Pacific Medical Second Opinion Sales Value by Region (%), 2024 VS 2031
  • Figure 27. South America Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. South America Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Middle East & Africa Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Middle East & Africa Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Key Countries/Regions Medical Second Opinion Sales Value (%), (2020-2031)
  • Figure 32. United States Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. United States Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
  • Figure 34. United States Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
  • Figure 35. Europe Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. Europe Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
  • Figure 37. Europe Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
  • Figure 38. China Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. China Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
  • Figure 40. China Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Japan Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Japan Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Japan Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
  • Figure 44. South Korea Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. South Korea Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
  • Figure 46. South Korea Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Southeast Asia Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Southeast Asia Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Southeast Asia Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
  • Figure 50. India Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. India Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
  • Figure 52. India Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Medical Second Opinion Industrial Chain
  • Figure 54. Medical Second Opinion Manufacturing Cost Structure
  • Figure 55. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 56. Bottom-up and Top-down Approaches for This Report
  • Figure 57. Data Triangulation
  • Figure 58. Key Executives Interviewed